Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.
作者信息
Kobori Hiroyuki, Fu Qi, Crowley Steven D, Gonzalez-Villalobos Romer A, Campos Ruy R
机构信息
Department of Medicine, Tulane University Health Sciences Center, LA, USA.
出版信息
J Appl Physiol (1985). 2010 Dec;109(6):2003. doi: 10.1152/japplphysiol.01160.2010.
Abstract
摘要
相似文献
1
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activated intrarenal renin-angiotensin system is correlated with high blood pressure in humans.
J Appl Physiol (1985). 2010 Dec;109(6):2003. doi: 10.1152/japplphysiol.01160.2010.
2
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
J Appl Physiol (1985). 2010 Dec;109(6):2006.
3
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
J Appl Physiol (1985). 2010 Dec;109(6):2006-7. doi: 10.1152/japplphysiol.01160.2010.
4
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Sympathetic nervous system, plasma volume, and hypertension.
J Appl Physiol (1985). 2010 Dec;109(6):2003. doi: 10.1152/japplphysiol.01160.2010.
5
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Dominant contributors for systemic hypertension--who leads, who follows?
J Appl Physiol (1985). 2010 Dec;109(6):2007-8. doi: 10.1152/japplphysiol.01160.2010.
6
7
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Systemic hypertension--a "ratologist" point of view.
J Appl Physiol (1985). 2010 Dec;109(6):2004. doi: 10.1152/japplphysiol.01160.2010.
8
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Chronic activation of sympathetic nervous system and systemic hypertension--stress shows the way.
J Appl Physiol (1985). 2010 Dec;109(6):2004-5. doi: 10.1152/japplphysiol.01160.2010.
9
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Intrarenal angiotensin II generation as a hypertensinogenic mechanism.
J Appl Physiol (1985). 2010 Dec;109(6):2013. doi: 10.1152/japplphysiol.01160.2010.
10
Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Systemic hypertension--involvement of the CNS to this complex puzzle.
J Appl Physiol (1985). 2010 Dec;109(6):2004. doi: 10.1152/japplphysiol.01160.2010.
本文引用的文献
1
Counterpoint: Activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension.
J Appl Physiol (1985). 2010 Dec;109(6):1998-2000; discussion 2015. doi: 10.1152/japplphysiol.00182.2010a.
2
Intrarenal angiotensin-converting enzyme induces hypertension in response to angiotensin I infusion.
J Am Soc Nephrol. 2011 Mar;22(3):449-59. doi: 10.1681/ASN.2010060624. Epub 2010 Nov 29.
3
Pressor responses to antihypertensive drug types.
Am J Hypertens. 2010 Sep;23(9):1031-7. doi: 10.1038/ajh.2010.114. Epub 2010 Aug 19.
4
An arcuate-ventrolateral periaqueductal gray reciprocal circuit participates in electroacupuncture cardiovascular inhibition.
Auton Neurosci. 2010 Dec 8;158(1-2):13-23. doi: 10.1016/j.autneu.2010.05.006. Epub 2010 Jun 30.
5
Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex.
Am J Physiol Heart Circ Physiol. 2010 Aug;299(2):H402-9. doi: 10.1152/ajpheart.00372.2010. Epub 2010 May 28.
6
Neural mechanism of electroacupuncture's hypotensive effects.
Auton Neurosci. 2010 Oct 28;157(1-2):24-30. doi: 10.1016/j.autneu.2010.03.015. Epub 2010 May 5.
7
Mechanisms of obesity-induced hypertension.
Hypertens Res. 2010 May;33(5):386-93. doi: 10.1038/hr.2010.9.
8
Is it the blood pressure or the blood vessel?
J Am Soc Hypertens. 2007 Jan-Feb;1(1):5-16. doi: 10.1016/j.jash.2006.11.001.
9
Neurogenic hypertension.
Exp Physiol. 2010 May;95(5):569-71. doi: 10.1113/expphysiol.2009.047282.
10
Electroacupuncture enhances preproenkephalin mRNA expression in rostral ventrolateral medulla of rats.
Neurosci Lett. 2010 Jun 21;477(2):61-5. doi: 10.1016/j.neulet.2010.04.025. Epub 2010 Apr 24.
Zotero 插件